Unicorn Biotechnologies has also made strides in research and development, executing benchmarking tests in their Emmet system that significantly reduce labor, process variability, and manufacturing costs for researchers and manufacturers working with cell culture, especially pluripotent stem cells.
Additionally, Unicorn Biotechnologies has expanded their operations. They have completed the renovation of a former carriage factory into world-class cell biology and engineering labs at their headquarters in Sheffield, UK. They have also filed three new non-provisional patents with the USPTO and completed the setup of an electronic quality management system, aiming for ISO 9001 accreditation and GMP certification within the next year.
Source : Newswire.ca